NewAmsterdam Pharma Company Financial Overview
NewAmsterdam Pharma Company's market cap is currently $4.22B. The company's EPS TTM is $-0.61; its P/E ratio is ―; NewAmsterdam Pharma Company is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.
